Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae

TM Ng, WX Khong, PNA Harris, PP De, A Chow… - PloS one, 2016 - journals.plos.org
… and piperacillin-tazobactam. Our results suggested that piperacillin-tazobactam can be as
… We were unable to ascertain if all patients received extended infusions. We attempted to …

Point-counterpoint: piperacillin-tazobactam should be used to treat infections with extended-spectrum-beta-lactamase-positive organisms

AN Schuetz, S Reyes, PD Tamma - Journal of clinical …, 2018 - Am Soc Microbiol
Beta-lactam/beta-lactamase inhibitor combination antimicrobials (… extended-spectrum-beta-lactamase
(ESBL)-producing Gram-negative bacteria (ESBL-GNR). Piperacillin-tazobactam (…

Optimal Piperacillin-Tazobactam Dosing Strategies against Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae

H Abodakpi, KT Chang, S Gao… - Antimicrobial agents …, 2019 - Am Soc Microbiol
… dosing strategies of piperacillin-tazobactam against ESBL-producing Enterobacteriaceae.
Given the variability of clinical responses to piperacillin-tazobactam, we hypothesized that the …

… controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing …

YB Seo, J Lee, YK Kim, SS Lee, J Lee, HY Kim… - BMC infectious …, 2017 - Springer
… Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam
for patients with extended-spectrum beta-lactamase bacteremia. Clin Infect Dis. 2015;…

Is piperacillin-tazobactam effective for the treatment of pyelonephritis caused by extended-spectrum β-lactamase–producing organisms?

SL Sharara, J Amoah, ZD Pana… - Clinical Infectious …, 2020 - academic.oup.com
… Similarly, when discussing the generalizability of their findings, the investigators of the
landmark MERINO trial mention that “whether piperacillin-tazobactam remains effective for urinary …

Piperacillin/tazobactam as an alternative antibiotic therapy to carbapenems in the treatment of urinary tract infections due to extended-spectrum β-lactamase …

H Guet-Revillet, E Tomini, A Emirian… - International journal of …, 2017 - Elsevier
Piperacillin/tazobactam (TZP) as an alternative treatment to carbapenems for infections
involving extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae (ESBL-PE) …

Outcomes analysis in patients with extended-spectrum beta-lactamase bacteremia empirically treated with piperacillin/tazobactam versus carbapenems

R John, P Colley, HL Nguyen… - Baylor University Medical …, 2019 - Taylor & Francis
… that when combined with beta-lactamase inhibitors, such as piperacillin/tazobactam (PTZ), …
shown mixed clinical efficacy of beta-lactam/beta-lactamase inhibitor (BLBLI) combinations …

Carbapenem versus Cefepime or Piperacillin-Tazobactam for Empiric Treatment of Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli …

GE Benanti, ART Brown, TL Shigle… - Antimicrobial agents …, 2019 - Am Soc Microbiol
… Empiric therapy with carbapenem-sparing regimens for bloodstream infections due to
extended-spectrum beta-lactamase-producing Enterobacteriaceae: results from the INCREMENT …

Piperacillin-tazobactam versus carbapenems for the treatment of nonbacteremic urinary tract infections due to extended-spectrum beta-lactamase-producing …

JB Tullos, LL Stoudenmire, JD Pouliot - Hospital Pharmacy, 2020 - journals.sagepub.com
… susceptible to beta-lactam/beta-lactamase inhibitors (BL/BLI) such as piperacillin-tazobactam
(… The purpose of this study is to determine the efficacy of piperacillin-tazobactam compared …

… of piperacillin/tazobactam as a carbapenem-sparing antibiotic for treatment of acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli

YK Yoon, JH Kim, JW Sohn, KS Yang… - International journal of …, 2017 - Elsevier
… The purpose of this study was to compare the clinical efficacy of piperacillin/tazobactam (TZP)
versus ertapenem in the treatment of adult patients with APN caused by ESBL-Ec. A …